Future diagnostic and therapeutic approaches in surgical infections.
Despite ongoing efforts to standardize therapy and improve management, the morbidity and mortality associated with surgical infections remain high. Continued innovation is required to improve outcomes further, particularly in the face of the increasing prevalence of multidrug resistant organisms. Although they remain in the experimental stages, a number of recent advances have the potential to have significant impact on the management and outcomes of surgical infections. These include novel diagnostic strategies, antimicrobials targeting microbial virulence factors, novel vaccines, and risk stratification based on genetic profiling.
Haas
Barbara
B
Department of Surgery, University of Toronto, Toronto, Ontario, M5G 1L5, Canada. barbara.haas@utoronto.ca
Nathens
Avery B
AB
D003428:Cross Infection / Q000175:diagnosis / Q000628:therapy; D004351:Drug Resistance; D006801:Humans; D017053:Infection Control / Q000639:trends*; D013530:Surgical Wound Infection / Q000175:diagnosis* / Q000628:therapy*; D014611:Vaccination